Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole D. Armstrong, James A. McCubrey, Ferdinando Nicoletti et al.|Oncotarget|2014Cited by 246
Akt as a therapeutic target in cancerLinda S. Steelman, James A. McCubrey, Kristin M. Stadelman et al.|Expert Opinion on Therapeutic Targets|2008Cited by 140
Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted TherapyMelissa L. Sokolosky, James A. McCubrey, Kristin M. Stadelman et al.|Oncotarget|2011Cited by 82